Studying the Roles of the Renin-Angiotensin System in Accelerating the Disease of High-Fat-Diet-Induced Diabetic Nephropathy in a db/db and ACE2 Double-Gene-Knockout Mouse Model
Diabetic nephropathy (DN) is a crucial metabolic health problem. The renin-angiotensin system (RAS) is well known to play an important role in DN. Abnormal RAS activity can cause the over-accumulation of angiotensin II (Ang II). Angiotensin-converting enzyme inhibitor (ACEI) administration has been...
Gespeichert in:
Veröffentlicht in: | International journal of molecular sciences 2023-12, Vol.25 (1), p.329 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 1 |
container_start_page | 329 |
container_title | International journal of molecular sciences |
container_volume | 25 |
creator | Chen, Cheng-Yi Lin, Meng-Wei Xie, Xing-Yang Lin, Cheng-Han Yang, Chung-Wei Wu, Pei-Ching Liu, Dung-Huan Wu, Chih-Jen Lin, Chih-Sheng |
description | Diabetic nephropathy (DN) is a crucial metabolic health problem. The renin-angiotensin system (RAS) is well known to play an important role in DN. Abnormal RAS activity can cause the over-accumulation of angiotensin II (Ang II). Angiotensin-converting enzyme inhibitor (ACEI) administration has been proposed as a therapy, but previous studies have also indicated that chymase, the enzyme that hydrolyzes angiotensin I to Ang II in an ACE-independent pathway, may play an important role in the progression of DN. Therefore, this study established a model of severe DN progression in a db/db and ACE2 KO mouse model (db and ACE2 double-gene-knockout mice) to explore the roles of RAS factors in DNA and changes in their activity after short-term (only 4 weeks) feeding of a high-fat diet (HFD) to 8-week-old mice. The results indicate that FD-fed db/db and ACE2 KO mice fed an HFD represent a good model for investigating the role of RAS in DN. An HFD promotes the activation of MAPK, including p-JNK and p-p38, as well as the RAS signaling pathway, leading to renal damage in mice. Blocking Ang II/AT1R could alleviate the progression of DN after administration of ACEI or chymase inhibitor (CI). Both ACE and chymase are highly involved in Ang II generation in HFD-induced DN; therefore, ACEI and CI are potential treatments for DN. |
doi_str_mv | 10.3390/ijms25010329 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10779113</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A779211939</galeid><sourcerecordid>A779211939</sourcerecordid><originalsourceid>FETCH-LOGICAL-c437t-866d6b6b5f4a90addb97db760136562f1886b5a4f081d43541057a3ca7a871a03</originalsourceid><addsrcrecordid>eNptkk1v1DAQhiMEoqVw44wsceFAWn8kcXJC0W6_RAsShbPl2JPES2IvsYO0P4t_iKNtqy1CPnjsed53NKNJkrcEnzJW4TOzGT3NMcGMVs-SY5JRmmJc8OcH8VHyyvsNxpTRvHqZHLGSYpZjfJz8uQuz3hnbodAD-uYG8Mi1-wdYY9PadsYFsN5YdLfzAUYUo1opGGCS4UG5Nh6kh0V7Zbo-vZAhXRsI6bXVswIdAdlAMAp9gW0_ua0M_W5xkkg3Z7pB0mpUr84pWru5GSC9BAvpZ-vUTzcHdOvmaH7rNAyvkxetHDy8ub9Pkh8X599XV-nN18vrVX2TqozxkJZFoYumaPI2kxWWWjcV1w0vMGFFXtCWlGVMyqzFJdEZyzOCcy6ZklyWnEjMTpJPe9_t3IygFdgwyUFsJzPKaSecNOJpxppedO63IJjzihAWHT7cO0zu1ww-iNH4OLdBWoj9CFoRlmUlraqIvv8H3bh5srG_haIl5bg8oDo5gDC2dbGwWkxFHWtSQiq2UKf_oeLRMBrlLLQm_j8RfNwL1OS8n6B9bJJgseyYONyxiL87HMwj_LBU7C_Dqsvv</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2912827089</pqid></control><display><type>article</type><title>Studying the Roles of the Renin-Angiotensin System in Accelerating the Disease of High-Fat-Diet-Induced Diabetic Nephropathy in a db/db and ACE2 Double-Gene-Knockout Mouse Model</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Chen, Cheng-Yi ; Lin, Meng-Wei ; Xie, Xing-Yang ; Lin, Cheng-Han ; Yang, Chung-Wei ; Wu, Pei-Ching ; Liu, Dung-Huan ; Wu, Chih-Jen ; Lin, Chih-Sheng</creator><creatorcontrib>Chen, Cheng-Yi ; Lin, Meng-Wei ; Xie, Xing-Yang ; Lin, Cheng-Han ; Yang, Chung-Wei ; Wu, Pei-Ching ; Liu, Dung-Huan ; Wu, Chih-Jen ; Lin, Chih-Sheng</creatorcontrib><description>Diabetic nephropathy (DN) is a crucial metabolic health problem. The renin-angiotensin system (RAS) is well known to play an important role in DN. Abnormal RAS activity can cause the over-accumulation of angiotensin II (Ang II). Angiotensin-converting enzyme inhibitor (ACEI) administration has been proposed as a therapy, but previous studies have also indicated that chymase, the enzyme that hydrolyzes angiotensin I to Ang II in an ACE-independent pathway, may play an important role in the progression of DN. Therefore, this study established a model of severe DN progression in a db/db and ACE2 KO mouse model (db and ACE2 double-gene-knockout mice) to explore the roles of RAS factors in DNA and changes in their activity after short-term (only 4 weeks) feeding of a high-fat diet (HFD) to 8-week-old mice. The results indicate that FD-fed db/db and ACE2 KO mice fed an HFD represent a good model for investigating the role of RAS in DN. An HFD promotes the activation of MAPK, including p-JNK and p-p38, as well as the RAS signaling pathway, leading to renal damage in mice. Blocking Ang II/AT1R could alleviate the progression of DN after administration of ACEI or chymase inhibitor (CI). Both ACE and chymase are highly involved in Ang II generation in HFD-induced DN; therefore, ACEI and CI are potential treatments for DN.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms25010329</identifier><identifier>PMID: 38203500</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>ACE inhibitors ; Analysis ; Angiotensin II ; Angiotensin-Converting Enzyme 2 - genetics ; Angiotensin-Converting Enzyme Inhibitors - pharmacology ; Animals ; Antiviral Agents ; Cholesterol ; Chymases - genetics ; Creatinine ; Diabetes ; Diabetes Mellitus ; Diabetic nephropathies ; Diabetic Nephropathies - genetics ; Diabetic nephropathy ; Diet therapy ; Diet, High-Fat ; Disease Models, Animal ; Enzymes ; Genes ; Glucose ; Hyperglycemia ; Inflammation ; Insulin resistance ; Kidney diseases ; Mice ; Mice, Knockout ; Obesity ; Peptide Hormones ; Peptides ; Renin-Angiotensin System ; Serine Proteases ; Type 2 diabetes</subject><ispartof>International journal of molecular sciences, 2023-12, Vol.25 (1), p.329</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c437t-866d6b6b5f4a90addb97db760136562f1886b5a4f081d43541057a3ca7a871a03</cites><orcidid>0000-0003-3634-9661 ; 0000-0003-1140-7933</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779113/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779113/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38203500$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Cheng-Yi</creatorcontrib><creatorcontrib>Lin, Meng-Wei</creatorcontrib><creatorcontrib>Xie, Xing-Yang</creatorcontrib><creatorcontrib>Lin, Cheng-Han</creatorcontrib><creatorcontrib>Yang, Chung-Wei</creatorcontrib><creatorcontrib>Wu, Pei-Ching</creatorcontrib><creatorcontrib>Liu, Dung-Huan</creatorcontrib><creatorcontrib>Wu, Chih-Jen</creatorcontrib><creatorcontrib>Lin, Chih-Sheng</creatorcontrib><title>Studying the Roles of the Renin-Angiotensin System in Accelerating the Disease of High-Fat-Diet-Induced Diabetic Nephropathy in a db/db and ACE2 Double-Gene-Knockout Mouse Model</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Diabetic nephropathy (DN) is a crucial metabolic health problem. The renin-angiotensin system (RAS) is well known to play an important role in DN. Abnormal RAS activity can cause the over-accumulation of angiotensin II (Ang II). Angiotensin-converting enzyme inhibitor (ACEI) administration has been proposed as a therapy, but previous studies have also indicated that chymase, the enzyme that hydrolyzes angiotensin I to Ang II in an ACE-independent pathway, may play an important role in the progression of DN. Therefore, this study established a model of severe DN progression in a db/db and ACE2 KO mouse model (db and ACE2 double-gene-knockout mice) to explore the roles of RAS factors in DNA and changes in their activity after short-term (only 4 weeks) feeding of a high-fat diet (HFD) to 8-week-old mice. The results indicate that FD-fed db/db and ACE2 KO mice fed an HFD represent a good model for investigating the role of RAS in DN. An HFD promotes the activation of MAPK, including p-JNK and p-p38, as well as the RAS signaling pathway, leading to renal damage in mice. Blocking Ang II/AT1R could alleviate the progression of DN after administration of ACEI or chymase inhibitor (CI). Both ACE and chymase are highly involved in Ang II generation in HFD-induced DN; therefore, ACEI and CI are potential treatments for DN.</description><subject>ACE inhibitors</subject><subject>Analysis</subject><subject>Angiotensin II</subject><subject>Angiotensin-Converting Enzyme 2 - genetics</subject><subject>Angiotensin-Converting Enzyme Inhibitors - pharmacology</subject><subject>Animals</subject><subject>Antiviral Agents</subject><subject>Cholesterol</subject><subject>Chymases - genetics</subject><subject>Creatinine</subject><subject>Diabetes</subject><subject>Diabetes Mellitus</subject><subject>Diabetic nephropathies</subject><subject>Diabetic Nephropathies - genetics</subject><subject>Diabetic nephropathy</subject><subject>Diet therapy</subject><subject>Diet, High-Fat</subject><subject>Disease Models, Animal</subject><subject>Enzymes</subject><subject>Genes</subject><subject>Glucose</subject><subject>Hyperglycemia</subject><subject>Inflammation</subject><subject>Insulin resistance</subject><subject>Kidney diseases</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Obesity</subject><subject>Peptide Hormones</subject><subject>Peptides</subject><subject>Renin-Angiotensin System</subject><subject>Serine Proteases</subject><subject>Type 2 diabetes</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkk1v1DAQhiMEoqVw44wsceFAWn8kcXJC0W6_RAsShbPl2JPES2IvsYO0P4t_iKNtqy1CPnjsed53NKNJkrcEnzJW4TOzGT3NMcGMVs-SY5JRmmJc8OcH8VHyyvsNxpTRvHqZHLGSYpZjfJz8uQuz3hnbodAD-uYG8Mi1-wdYY9PadsYFsN5YdLfzAUYUo1opGGCS4UG5Nh6kh0V7Zbo-vZAhXRsI6bXVswIdAdlAMAp9gW0_ua0M_W5xkkg3Z7pB0mpUr84pWru5GSC9BAvpZ-vUTzcHdOvmaH7rNAyvkxetHDy8ub9Pkh8X599XV-nN18vrVX2TqozxkJZFoYumaPI2kxWWWjcV1w0vMGFFXtCWlGVMyqzFJdEZyzOCcy6ZklyWnEjMTpJPe9_t3IygFdgwyUFsJzPKaSecNOJpxppedO63IJjzihAWHT7cO0zu1ww-iNH4OLdBWoj9CFoRlmUlraqIvv8H3bh5srG_haIl5bg8oDo5gDC2dbGwWkxFHWtSQiq2UKf_oeLRMBrlLLQm_j8RfNwL1OS8n6B9bJJgseyYONyxiL87HMwj_LBU7C_Dqsvv</recordid><startdate>20231226</startdate><enddate>20231226</enddate><creator>Chen, Cheng-Yi</creator><creator>Lin, Meng-Wei</creator><creator>Xie, Xing-Yang</creator><creator>Lin, Cheng-Han</creator><creator>Yang, Chung-Wei</creator><creator>Wu, Pei-Ching</creator><creator>Liu, Dung-Huan</creator><creator>Wu, Chih-Jen</creator><creator>Lin, Chih-Sheng</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3634-9661</orcidid><orcidid>https://orcid.org/0000-0003-1140-7933</orcidid></search><sort><creationdate>20231226</creationdate><title>Studying the Roles of the Renin-Angiotensin System in Accelerating the Disease of High-Fat-Diet-Induced Diabetic Nephropathy in a db/db and ACE2 Double-Gene-Knockout Mouse Model</title><author>Chen, Cheng-Yi ; Lin, Meng-Wei ; Xie, Xing-Yang ; Lin, Cheng-Han ; Yang, Chung-Wei ; Wu, Pei-Ching ; Liu, Dung-Huan ; Wu, Chih-Jen ; Lin, Chih-Sheng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c437t-866d6b6b5f4a90addb97db760136562f1886b5a4f081d43541057a3ca7a871a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>ACE inhibitors</topic><topic>Analysis</topic><topic>Angiotensin II</topic><topic>Angiotensin-Converting Enzyme 2 - genetics</topic><topic>Angiotensin-Converting Enzyme Inhibitors - pharmacology</topic><topic>Animals</topic><topic>Antiviral Agents</topic><topic>Cholesterol</topic><topic>Chymases - genetics</topic><topic>Creatinine</topic><topic>Diabetes</topic><topic>Diabetes Mellitus</topic><topic>Diabetic nephropathies</topic><topic>Diabetic Nephropathies - genetics</topic><topic>Diabetic nephropathy</topic><topic>Diet therapy</topic><topic>Diet, High-Fat</topic><topic>Disease Models, Animal</topic><topic>Enzymes</topic><topic>Genes</topic><topic>Glucose</topic><topic>Hyperglycemia</topic><topic>Inflammation</topic><topic>Insulin resistance</topic><topic>Kidney diseases</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Obesity</topic><topic>Peptide Hormones</topic><topic>Peptides</topic><topic>Renin-Angiotensin System</topic><topic>Serine Proteases</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Cheng-Yi</creatorcontrib><creatorcontrib>Lin, Meng-Wei</creatorcontrib><creatorcontrib>Xie, Xing-Yang</creatorcontrib><creatorcontrib>Lin, Cheng-Han</creatorcontrib><creatorcontrib>Yang, Chung-Wei</creatorcontrib><creatorcontrib>Wu, Pei-Ching</creatorcontrib><creatorcontrib>Liu, Dung-Huan</creatorcontrib><creatorcontrib>Wu, Chih-Jen</creatorcontrib><creatorcontrib>Lin, Chih-Sheng</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Cheng-Yi</au><au>Lin, Meng-Wei</au><au>Xie, Xing-Yang</au><au>Lin, Cheng-Han</au><au>Yang, Chung-Wei</au><au>Wu, Pei-Ching</au><au>Liu, Dung-Huan</au><au>Wu, Chih-Jen</au><au>Lin, Chih-Sheng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Studying the Roles of the Renin-Angiotensin System in Accelerating the Disease of High-Fat-Diet-Induced Diabetic Nephropathy in a db/db and ACE2 Double-Gene-Knockout Mouse Model</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2023-12-26</date><risdate>2023</risdate><volume>25</volume><issue>1</issue><spage>329</spage><pages>329-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Diabetic nephropathy (DN) is a crucial metabolic health problem. The renin-angiotensin system (RAS) is well known to play an important role in DN. Abnormal RAS activity can cause the over-accumulation of angiotensin II (Ang II). Angiotensin-converting enzyme inhibitor (ACEI) administration has been proposed as a therapy, but previous studies have also indicated that chymase, the enzyme that hydrolyzes angiotensin I to Ang II in an ACE-independent pathway, may play an important role in the progression of DN. Therefore, this study established a model of severe DN progression in a db/db and ACE2 KO mouse model (db and ACE2 double-gene-knockout mice) to explore the roles of RAS factors in DNA and changes in their activity after short-term (only 4 weeks) feeding of a high-fat diet (HFD) to 8-week-old mice. The results indicate that FD-fed db/db and ACE2 KO mice fed an HFD represent a good model for investigating the role of RAS in DN. An HFD promotes the activation of MAPK, including p-JNK and p-p38, as well as the RAS signaling pathway, leading to renal damage in mice. Blocking Ang II/AT1R could alleviate the progression of DN after administration of ACEI or chymase inhibitor (CI). Both ACE and chymase are highly involved in Ang II generation in HFD-induced DN; therefore, ACEI and CI are potential treatments for DN.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38203500</pmid><doi>10.3390/ijms25010329</doi><orcidid>https://orcid.org/0000-0003-3634-9661</orcidid><orcidid>https://orcid.org/0000-0003-1140-7933</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2023-12, Vol.25 (1), p.329 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10779113 |
source | MDPI - Multidisciplinary Digital Publishing Institute; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | ACE inhibitors Analysis Angiotensin II Angiotensin-Converting Enzyme 2 - genetics Angiotensin-Converting Enzyme Inhibitors - pharmacology Animals Antiviral Agents Cholesterol Chymases - genetics Creatinine Diabetes Diabetes Mellitus Diabetic nephropathies Diabetic Nephropathies - genetics Diabetic nephropathy Diet therapy Diet, High-Fat Disease Models, Animal Enzymes Genes Glucose Hyperglycemia Inflammation Insulin resistance Kidney diseases Mice Mice, Knockout Obesity Peptide Hormones Peptides Renin-Angiotensin System Serine Proteases Type 2 diabetes |
title | Studying the Roles of the Renin-Angiotensin System in Accelerating the Disease of High-Fat-Diet-Induced Diabetic Nephropathy in a db/db and ACE2 Double-Gene-Knockout Mouse Model |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T02%3A51%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Studying%20the%20Roles%20of%20the%20Renin-Angiotensin%20System%20in%20Accelerating%20the%20Disease%20of%20High-Fat-Diet-Induced%20Diabetic%20Nephropathy%20in%20a%20db/db%20and%20ACE2%20Double-Gene-Knockout%20Mouse%20Model&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Chen,%20Cheng-Yi&rft.date=2023-12-26&rft.volume=25&rft.issue=1&rft.spage=329&rft.pages=329-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms25010329&rft_dat=%3Cgale_pubme%3EA779211939%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2912827089&rft_id=info:pmid/38203500&rft_galeid=A779211939&rfr_iscdi=true |